We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About ICE Bioscience Stock

Invest in or calculate the value of your shares in ICE Bioscience or other pre-IPO companies through EquityZen's platform.

Get Started

ICE Bioscience Stock (ICBI)

ICE Bioscience is an Innovative CRO+ Explorer company .

About ICE Bioscience Stock

Founded

2010

Industries

Software, Artificial Intelligence, Financial Services

ICE Bioscience is an Innovative CRO+ Explorer company focusing in early drug discovery services from target validation to pre-clinical candidate identification, with strong capabilities and technologies in Immunology and Oncology, Cardiovascular and CNS diseases areas. ICE Bioscience provides high professional communication and flexible collaboration models, to speed up drug discovery process better and faster. ICE Bioscience has wide target-based panel screening platform ready-to-use, we keep trying to expand diverse techniques related to Biology and Pharmacology, to support various drug discovery purpose for different indications and clinical needs, we do have quite a lot of new assays development experience and passion, to accomplish target identification and assay validation, compounds screening from hit to lead, to pre-clinical drug candidate selection.

ICE Bioscience Press Mentions

Stay in the know about the latest news on ICE Bioscience

Locked Features

Join now and verify your accreditation status to gain access to:

  • ICE Bioscience Current Valuation
  • ICE Bioscience Stock Price
  • ICE Bioscience Management
  • Available deals in ICE Bioscience and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • ICE Bioscience Cap Table and Funding History by Share Class and Liquidity Preferences
    • ICE Bioscience Revenue and Financials
    • ICE Bioscience Highlights
    • ICE Bioscience Business Model
    • ICE Bioscience Risk Factors
  • ICE Bioscience Research Report from SACRA Research
Join Now

Trading ICE Bioscience Stock

How to invest in ICE Bioscience stock?

Accredited investors can buy pre-IPO stock in companies like ICE Bioscience through EquityZen funds. These investments are made available by existing ICE Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell ICE Bioscience stock?

Shareholders can sell their ICE Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."